| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |